TeraRecon unveiled two digital, multi-functional, color Doppler systems targeted for the portable ultrasound market on Sunday at the RSNA meeting. With the UF-785XTD and the UF-780XTD, the company is attempting to bring the functionality of portable ultrasound systems a step closer to cart-based machines.
TeraRecon unveiled two digital, multi-functional, color Doppler systems targeted for the portable ultrasound market on Sunday at the RSNA meeting. With the UF-785XTD and the UF-780XTD, the company is attempting to bring the functionality of portable ultrasound systems a step closer to cart-based machines.
The two new products provide more advanced capabilities at an affordable price for potential customers in general practice and office settings.
UF-785XTD, developed for cardiovascular applications, offers three probe connections, which are unique among portable scanners, plus dual beam processing. The UF-780XTD, for general applications, comes with two simultaneous probe connections plus single-beam processing. Both systems feature a high-tech portable ultrasound scanner design and are equipped with 15-inch LCD monitors with XGA image quality. Imaging modes for both include 2D, tissue harmonics, M-mode, color Doppler, spectral Doppler (CW/PW), and power Doppler.
The new systems possess EKG capability, hard drive and DVD-R capability, and a built-in capability for efficient video clip recordings. Transducers and software upgrades are compatible across TeraRecon's XTD product line. Neither has yet cleared the FDA, but the company expects market clearance by year's end or first quarter of 2006.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.